Please assess the completion status of the following clinical trial:

Trial Title: Quetiapine in Postpartum Depression

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of signed informed consent.~* Female patients with severe postpartum depressive disorders with psychotic symptoms and a minimum HAM-D cut off score of 20 points~Exclusion Criteria:~* Woman with pre-existing psychotic disorder~* Patients with alcohol or substance abuse or dependence~* Patients who pose an imminent risk of suicide or danger to self or others

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- Quetiapine Fumarate 150 - 800mg (Type: EXPERIMENTAL): Quetiapine 150-800mg

Based on this trial design, predict the completion outcome and termination type (if applicable).